A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2749 participants.

Also called NCT05803421

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 2,749 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05803421
Other papers using this trial's data
  • Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial Lancet (London, England), 2026-10-17 DOI, PubMed 42815506 PubMed links an erratum for this paper. Erratum: PMID 42880309

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States, Argentina, Austria, Brazil, Czechia, Germany, Greece, India, Italy, Mexico, Puerto Rico, Romania, Slovakia, South Korea, Spain, Türkiye (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05803421. Randomized; no masking; primary purpose treatment. Start 2023-04-03 (actual); primary completion 2026-03-16 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk
Acronym
ACHIEVE-4
Condition
Obesity
Condition
Overweight or Obesity
Condition
Overweight
Condition
Cardiovascular Diseases
Intervention (Drug)
Orforglipron
Intervention (Drug)
Insulin Glargine
Lead sponsor
Eli Lilly and Company (class: industry)

Record details

Record id
cardio:ct-nct05803421
Content hash
2add84c094d45621f7d560cdb1e09d16d7563e6951676684b140b2b693c7205d